API Holdings (Pharmeasy)

Industry Analysis

The Indian healthcare market, valued at US$ 110 billion in 2016, is projected to reach US$ 638 billion by 2025. As of 2024, the sector employs 7.5 million individuals, positioning it as one of the largest employment sectors in the country. However, the industry faces a critical shortage of healthcare professionals, with only 1.7 nurses per 1,000 people and a doctor-patient ratio of 1:1,500. As a result, the demand for healthcare professionals in India is expected to double by 2030. In response to these challenges, the 2024-25 Union Budget has allocated Rs. 89,287 crores (US$ 10.7 billion), which includes Rs. 50,000 crores (US$ 6.8 billion) for a dedicated credit program aimed at enhancing healthcare infrastructure and expanding digital services.
(Source: Industry Research Report and Annual Report)

Overview of API Holdings (Pharmeasy)

Founded in 2012, API Holdings has established itself as a leader in India's digital healthcare sector. Operating under the brand name PharmEasy, it has grown to become the country’s largest digital healthcare platform, as measured by the GMV of products and services sold as of March 31, 2021. Headquartered in Ghatkopar West, Mumbai, the company offers an integrated, end-to-end solution designed to meet the healthcare needs of a wide range of consumers. API Holdings provides services to diverse stakeholders, including consumers, pharmaceutical companies, wholesalers, pharmacies, hospitals, doctors, clinics, and diagnostic labs, creating a seamless and connected healthcare ecosystem throughout India.